Malaysia's health ministry said it has temporarily halted the use of two influenza vaccines, SK Bioscience's SKYCellflu Quadrivalent and Sanofi's Vaxigrip Tetra, as a precautionary measure after at least four dozen people who received them in South Korea reportedly died, reported the Malay Mail.
The country's senior director of pharmaceutical services said the ministry had taken note of a statement issued by Singapore's health ministry on October 25.
Datin Faridah Aryani said the ministry was also informed by Sanofi Pasteur that the batch numbers of the vaccine used in South Korea are not marketed to other countries, including Malaysia.
She also said there were no reported deaths in the country linked to both quadrivalent influenza vaccines to date.
To read more NewsPoints articles, click here.